Your session is about to expire
← Back to Search
Modified Diabetes Prevention Program for Obesity, Weight Loss, and Prediabetes (DPP-TOO Trial)
N/A
Waitlist Available
Led By Courtney E Gamston, PharmD
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial hopes to show that community pharmacies can help with weight loss and diabetes prevention, improving health outcomes.
Eligible Conditions
- Obesity
- Prediabetes
- Weight Loss
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in A1c
Weight loss
Secondary study objectives
Blood pressure change
Physical activity change
Proportion of patients meeting DPP program criteria
Other study objectives
Change in Processes of Change for Weight Loss including the following processes: emotional re-evaluation, weight consequences evaluation, supporting relationships, and weight management actions
Change in Stage of Change for Weight Loss
Change in level of confidence in ability to motivate oneself to maintain dietary and physical activity behaviors for at least 6 months
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Modified DPPExperimental Treatment1 Intervention
Participants in this arm will participate in the modified Diabetes Prevention Program curriculum.
Find a Location
Who is running the clinical trial?
Auburn UniversityLead Sponsor
79 Previous Clinical Trials
14,559 Total Patients Enrolled
4 Trials studying Obesity
5,930 Patients Enrolled for Obesity
Courtney E Gamston, PharmDPrincipal InvestigatorAuburn University Harrison School of Pharmacy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant.
Research Study Groups:
This trial has the following groups:- Group 1: Modified DPP
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.